SCHEMBL7986351

SCHEMBL7986351

Nc1cccc(-c2nc3ncn(CCCc4ccccc4)c3c(=O)[nH]2)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
LMNA P02545 1/20 0.50
POLB P06746 1/20 0.50
MAPK1 P28482 1/20 0.50
CNOT7 Q9UIV1 2/20 0.44
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
HPGD P15428 2/20 0.41
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
RAB9A P51151 1/20 0.38
HSD17B10 Q99714 1/20 0.38
FAAH O00519 1/20 0.38
RECQL P46063 1/20 0.37
MDM2 Q00987 1/20 0.37
PRMT1 Q99873 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988580 0.94 ALDH1A1 (0.44) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7984240 0.90 LMNA (0.58) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7984488 0.89 LMNA (0.53) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7984655 0.89 SMN1; SMN2 (0.53) KDM4ECNOT7ALDH1A1SMN1; SMN2KMT2A
SCHEMBL7974290 0.88 KDM4E (0.50) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7992300 0.88 LMNA (0.50) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7987627 0.88 KDM4E (0.50) KDM4ELMNAPOLBMAPK1CNOT7
Hydrochloric Acid SCHEMBL7987658 0.88 SMN1; SMN2 (0.53) KDM4ECNOT7ALDH1A1SMN1; SMN2KMT2A
SCHEMBL7984893 0.85 KDM4E (0.50) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7986359 0.84 CNOT7 (0.52) KDM4ELMNAPOLBMAPK1CNOT7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed